{"id":"https://openalex.org/W1992786986","doi":"https://doi.org/10.1007/bf00518176","title":"A comparative assay of nefopam, morphine and d-amphetamine","display_name":"A comparative assay of nefopam, morphine and d-amphetamine","publication_year":1987,"publication_date":"1987-01-01","ids":{"openalex":"https://openalex.org/W1992786986","doi":"https://doi.org/10.1007/bf00518176","mag":"1992786986","pmid":"https://pubmed.ncbi.nlm.nih.gov/3104949"},"language":"en","primary_location":{"id":"doi:10.1007/bf00518176","doi":"https://doi.org/10.1007/bf00518176","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00518176","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110870318","display_name":"Donald R. Jasinski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"id":"https://openalex.org/I1336377119","display_name":"Substance Abuse and Mental Health Services Administration","ror":"https://ror.org/03t3qg659","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1336377119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. R. Jasinski","raw_affiliation_strings":["Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute on Drug Abuse Addiction Research Center, 21224, Baltimore, MD, USA","Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute on Drug Abuse Addiction Research Center, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute on Drug Abuse Addiction Research Center, 21224, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1327069482","https://openalex.org/I1336377119"]},{"raw_affiliation_string":"Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute on Drug Abuse Addiction Research Center, Baltimore, USA","institution_ids":["https://openalex.org/I1327069482","https://openalex.org/I1336377119"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060972692","display_name":"Kenzie L. Preston","orcid":"https://orcid.org/0000-0003-0603-2479","observed_orcids":["https://orcid.org/0000-0003-0603-2479"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"id":"https://openalex.org/I1336377119","display_name":"Substance Abuse and Mental Health Services Administration","ror":"https://ror.org/03t3qg659","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1336377119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. L. Preston","raw_affiliation_strings":["Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute on Drug Abuse Addiction Research Center, 21224, Baltimore, MD, USA","Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute on Drug Abuse Addiction Research Center, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute on Drug Abuse Addiction Research Center, 21224, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1327069482","https://openalex.org/I1336377119"]},{"raw_affiliation_string":"Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute on Drug Abuse Addiction Research Center, Baltimore, USA","institution_ids":["https://openalex.org/I1327069482","https://openalex.org/I1336377119"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.1389,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.31982153,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"91","issue":"3","first_page":"273","last_page":"278"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6621000170707703,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6621000170707703,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.1023000031709671,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.06700000166893005,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nefopam","display_name":"nefopam","score":1.0},{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/d-amphetamine","display_name":"d-amphetamine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.8309999704360962},{"id":"https://openalex.org/keywords/subjective-effects","display_name":"subjective effects","score":0.628000020980835},{"id":"https://openalex.org/keywords/physiological-effects","display_name":"physiological effects","score":0.5789999961853027},{"id":"https://openalex.org/keywords/drug-discrimination","display_name":"drug discrimination","score":0.5249999761581421},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.7099999785423279},{"id":"https://openalex.org/keywords/non-opioid-analgesics","display_name":"non-opioid analgesics","score":0.8019999861717224},{"id":"https://openalex.org/keywords/stimulant-effects","display_name":"stimulant effects","score":0.6140000224113464},{"id":"https://openalex.org/keywords/drug-potency","display_name":"drug potency","score":0.4819999933242798},{"id":"https://openalex.org/keywords/substance-abusers","display_name":"substance abusers","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.8686410188674927},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.7931766510009766},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.7467038035392761},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.579105019569397},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5767037868499756},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5212472081184387},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.46715229749679565},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3588826060295105},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3340800702571869},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.33184462785720825},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1072697639465332},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.100222647190094},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.05987277626991272},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05276501178741455}],"mesh":[{"descriptor_ui":"D001519","descriptor_name":"Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009340","descriptor_name":"Nefopam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010079","descriptor_name":"Oxazocines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf00518176","doi":"https://doi.org/10.1007/bf00518176","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00518176","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:3104949","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3104949","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W119826681","https://openalex.org/W240352522","https://openalex.org/W1963809241","https://openalex.org/W1974746343","https://openalex.org/W1991536033","https://openalex.org/W1993863683","https://openalex.org/W2005381654","https://openalex.org/W2011346895","https://openalex.org/W2027728223","https://openalex.org/W2033204421","https://openalex.org/W2054092703","https://openalex.org/W2064588775","https://openalex.org/W2073042401","https://openalex.org/W2085033156","https://openalex.org/W2092243064","https://openalex.org/W2336023830","https://openalex.org/W2404061643","https://openalex.org/W2404608966","https://openalex.org/W2412771981","https://openalex.org/W2461486064","https://openalex.org/W2796751650","https://openalex.org/W3142640589","https://openalex.org/W6816825550"],"related_works":["https://openalex.org/W2412771981","https://openalex.org/W2092243064","https://openalex.org/W2004496093","https://openalex.org/W119826681","https://openalex.org/W1966254643","https://openalex.org/W2044293558","https://openalex.org/W1981933712","https://openalex.org/W1976309976","https://openalex.org/W17693492","https://openalex.org/W2131277994"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}